 Daniel Kao
Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salmonella enterica | 2 | 2022 | 49 | 1.320 |
Why?
| | Intestinal Mucosa | 6 | 2018 | 532 | 0.900 |
Why?
| | Colon | 2 | 2016 | 233 | 0.900 |
Why?
| | Adenosine | 4 | 2022 | 203 | 0.860 |
Why?
| | Metabolomics | 3 | 2018 | 521 | 0.760 |
Why?
| | Fimbriae Proteins | 3 | 2009 | 15 | 0.640 |
Why?
| | 5'-Nucleotidase | 1 | 2017 | 35 | 0.580 |
Why?
| | Pseudomonas aeruginosa | 3 | 2009 | 298 | 0.570 |
Why?
| | Monosaccharides | 1 | 2015 | 11 | 0.510 |
Why?
| | Receptors, Fc | 1 | 2015 | 45 | 0.500 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 295 | 0.470 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2016 | 470 | 0.450 |
Why?
| | Immunoglobulin G | 3 | 2015 | 770 | 0.450 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1481 | 0.420 |
Why?
| | Pseudomonas Vaccines | 1 | 2009 | 1 | 0.330 |
Why?
| | Peptides | 3 | 2009 | 848 | 0.310 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2017 | 284 | 0.300 |
Why?
| | Cell Line | 4 | 2018 | 2637 | 0.300 |
Why?
| | Vaccines, Synthetic | 2 | 2007 | 124 | 0.290 |
Why?
| | Epithelial Cells | 3 | 2018 | 951 | 0.290 |
Why?
| | Fimbriae, Bacterial | 1 | 2007 | 25 | 0.290 |
Why?
| | Pseudomonas Infections | 2 | 2007 | 184 | 0.270 |
Why?
| | Receptors, Cell Surface | 1 | 2007 | 355 | 0.250 |
Why?
| | Colitis | 2 | 2018 | 223 | 0.240 |
Why?
| | Magnetic Resonance Imaging | 1 | 2016 | 3053 | 0.240 |
Why?
| | Peptide Fragments | 1 | 2007 | 666 | 0.220 |
Why?
| | Mice | 8 | 2018 | 14869 | 0.220 |
Why?
| | NADH Dehydrogenase | 1 | 2022 | 17 | 0.200 |
Why?
| | Nucleosides | 1 | 2022 | 25 | 0.200 |
Why?
| | Mice, Knockout | 3 | 2017 | 2570 | 0.200 |
Why?
| | Guanosine Triphosphate | 1 | 2022 | 85 | 0.200 |
Why?
| | Neutrophils | 2 | 2018 | 1176 | 0.200 |
Why?
| | Microbial Sensitivity Tests | 1 | 2022 | 300 | 0.180 |
Why?
| | Animals | 12 | 2018 | 31706 | 0.170 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 430 | 0.170 |
Why?
| | Tryptophan | 2 | 2017 | 136 | 0.160 |
Why?
| | Tight Junctions | 2 | 2018 | 68 | 0.150 |
Why?
| | Polyphosphates | 1 | 2018 | 33 | 0.150 |
Why?
| | Pyrophosphatases | 1 | 2018 | 22 | 0.150 |
Why?
| | Escherichia coli | 1 | 2022 | 720 | 0.150 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2018 | 44 | 0.150 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2017 | 68 | 0.150 |
Why?
| | Receptors, Interleukin-10 | 1 | 2018 | 6 | 0.150 |
Why?
| | Signal Transduction | 4 | 2018 | 4513 | 0.150 |
Why?
| | Receptor, Cannabinoid, CB2 | 1 | 2017 | 3 | 0.150 |
Why?
| | Nucleotidases | 1 | 2017 | 7 | 0.150 |
Why?
| | Nucleotides | 1 | 2018 | 112 | 0.150 |
Why?
| | Cricetulus | 2 | 2015 | 97 | 0.140 |
Why?
| | Bacterial Load | 1 | 2017 | 58 | 0.140 |
Why?
| | Protein Binding | 2 | 2015 | 1890 | 0.140 |
Why?
| | CHO Cells | 2 | 2015 | 138 | 0.140 |
Why?
| | Cricetinae | 2 | 2015 | 253 | 0.140 |
Why?
| | Interleukin-10 Receptor alpha Subunit | 1 | 2017 | 5 | 0.140 |
Why?
| | Amino Acid Sequence | 4 | 2009 | 1982 | 0.140 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 44 | 0.140 |
Why?
| | Inflammation | 2 | 2017 | 2480 | 0.130 |
Why?
| | Molecular Sequence Data | 4 | 2009 | 2785 | 0.130 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2015 | 5 | 0.130 |
Why?
| | Antigens, CD20 | 1 | 2015 | 27 | 0.130 |
Why?
| | Salmonella typhimurium | 1 | 2017 | 164 | 0.130 |
Why?
| | Cellular Microenvironment | 1 | 2016 | 78 | 0.130 |
Why?
| | Complement C1q | 1 | 2015 | 36 | 0.130 |
Why?
| | Glycoside Hydrolases | 1 | 2015 | 30 | 0.130 |
Why?
| | Indoles | 1 | 2018 | 304 | 0.130 |
Why?
| | Receptors, IgG | 1 | 2015 | 67 | 0.130 |
Why?
| | Electrochemical Techniques | 1 | 2016 | 45 | 0.130 |
Why?
| | Glycosylation | 1 | 2015 | 130 | 0.130 |
Why?
| | Glycopeptides | 1 | 2015 | 43 | 0.120 |
Why?
| | Claudin-1 | 1 | 2015 | 21 | 0.120 |
Why?
| | Crohn Disease | 1 | 2017 | 196 | 0.120 |
Why?
| | Adenine | 1 | 2016 | 219 | 0.110 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 493 | 0.110 |
Why?
| | Amino Acids | 1 | 2016 | 448 | 0.100 |
Why?
| | Energy Metabolism | 1 | 2017 | 731 | 0.100 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2015 | 345 | 0.100 |
Why?
| | Microbiota | 1 | 2018 | 647 | 0.090 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 4694 | 0.080 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2007 | 353 | 0.080 |
Why?
| | Protein Structure, Secondary | 2 | 2007 | 325 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2009 | 796 | 0.080 |
Why?
| | Vaccines, Conjugate | 1 | 2009 | 59 | 0.080 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 2710 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2016 | 3886 | 0.080 |
Why?
| | Surface Plasmon Resonance | 2 | 2006 | 81 | 0.070 |
Why?
| | Dextran Sulfate | 2 | 2018 | 70 | 0.070 |
Why?
| | Crystallization | 1 | 2007 | 136 | 0.070 |
Why?
| | Antigens, Bacterial | 1 | 2007 | 112 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2007 | 218 | 0.070 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1144 | 0.070 |
Why?
| | Humans | 9 | 2018 | 114689 | 0.070 |
Why?
| | Recombinant Proteins | 1 | 2009 | 1230 | 0.070 |
Why?
| | Viral Envelope Proteins | 1 | 2006 | 73 | 0.060 |
Why?
| | Models, Molecular | 2 | 2007 | 1369 | 0.060 |
Why?
| | Wound Healing | 2 | 2018 | 258 | 0.060 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2007 | 473 | 0.060 |
Why?
| | Immunization | 1 | 2007 | 397 | 0.060 |
Why?
| | Bacterial Vaccines | 1 | 2004 | 61 | 0.060 |
Why?
| | Antibodies, Bacterial | 1 | 2004 | 119 | 0.060 |
Why?
| | Disease Models, Animal | 3 | 2018 | 3535 | 0.060 |
Why?
| | Membrane Glycoproteins | 1 | 2006 | 430 | 0.060 |
Why?
| | Homeostasis | 2 | 2018 | 573 | 0.050 |
Why?
| | Survival Rate | 1 | 2007 | 1644 | 0.050 |
Why?
| | Cell Movement | 2 | 2018 | 869 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2017 | 1131 | 0.050 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2018 | 8 | 0.040 |
Why?
| | Tight Junction Proteins | 1 | 2018 | 9 | 0.040 |
Why?
| | Dinucleoside Phosphates | 1 | 2018 | 24 | 0.040 |
Why?
| | Ileum | 1 | 2017 | 90 | 0.040 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2017 | 39 | 0.030 |
Why?
| | Organ Specificity | 1 | 2017 | 268 | 0.030 |
Why?
| | Kynurenine | 1 | 2017 | 81 | 0.030 |
Why?
| | Intestines | 1 | 2018 | 326 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2017 | 316 | 0.030 |
Why?
| | Interleukin-10 | 1 | 2017 | 299 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 128 | 0.030 |
Why?
| | Cell Communication | 1 | 2016 | 280 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 911 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2017 | 719 | 0.030 |
Why?
| | Female | 2 | 2017 | 59511 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2015 | 337 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1313 | 0.030 |
Why?
| | Hypoxia | 1 | 2017 | 958 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2017 | 501 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3003 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2320 | 0.020 |
Why?
| | Neutralization Tests | 1 | 2006 | 63 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2006 | 135 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2006 | 176 | 0.020 |
Why?
| | Antigens, Viral | 1 | 2006 | 176 | 0.020 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2006 | 92 | 0.020 |
Why?
| | Antibody Affinity | 1 | 2004 | 52 | 0.010 |
Why?
| | Cross Reactions | 1 | 2004 | 117 | 0.010 |
Why?
| | Vaccines, Subunit | 1 | 2004 | 41 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 797 | 0.010 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 201 | 0.010 |
Why?
| | Blotting, Western | 1 | 2006 | 1147 | 0.010 |
Why?
| | Rabbits | 1 | 2004 | 733 | 0.010 |
Why?
| | Ligands | 1 | 2004 | 562 | 0.010 |
Why?
| | Kinetics | 1 | 2006 | 1551 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1083 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 26737 | 0.010 |
Why?
| | Male | 1 | 2017 | 55599 | 0.010 |
Why?
|
|
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|